Loading clinical trials...
Loading clinical trials...
A Randomized, Double Blind, Phase 2b Study to Evaluate the Effect of ORMD-0801 Compared to Placebo on Endogenous Glucose Production in Patients With Type 2 Diabetes Mellitus
Conditions
Interventions
ORMD-0801
Placebo
Locations
1
United States
Orange County Research Center (OCRC) 14351 Myford Rd., Suite B, Tustin, CA 92780
Tustin, California, United States
Start Date
November 23, 2020
Primary Completion Date
June 7, 2022
Completion Date
June 7, 2022
Last Updated
May 7, 2024
NCT06513026
NCT06329375
NCT06945406
NCT06959901
NCT06574035
NCT06861062
Lead Sponsor
Oramed, Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions